An interventional study of Bosiqing and abilify in Bioequivalence, sponsored by Chengdu Kanghong Pharmaceutical Group Co., Ltd.. Status unknown at 1 site in China. Open to participants aged 45 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-07-28.
Sponsored by Chengdu Kanghong Pharmaceutical Group Co., Ltd. · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
To compare the rate and extent of absorption of Aripiprazole Orally disintegrating tablets 10 mg of Chengdu Kanghong Pharmaceutical Group Co.,Ltd, China and ABILIFY (Aripiprazole) 10 mg orodispersible tablets of Otsuka Pharmaceutical Europe Ltd. in healthy, adult, human subjects under fasting/fed condition as well as to monitor the safety and tolerability of subjects.
Chengdu Kanghong Pharmaceutical Group Co., Ltd. is the lead sponsor of 11 studies on the registry; 8 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
1)Subjects with family history of muscular dystonia or the subject has had the drug source dystonia.
2)Subject with history of a asthma. 3)Subject with any (acute or chronic) history of mental illness or have family history of mental illness.
4)Subject have alzheimer's or alzheimer's disease. 5)Subject was hospitalized within 60 days prior to the first dose of the study drug 6)Subject smoking more than five cigarettes within 1 month prior to the first dose study drug.
7)History or presence of significant easy bruising or bleeding 8)History or presence of drug abuse. 9)History of allergic reactions. 10)History or presence of taking psychotropic drugs。 11)Subjects having positive urine screen for drugs of abuse including Methamphetamine, MDMA, ketamine, morphine, heroin.
12)Any treatment which could bring about induction or inhibition of hepatic microsomal enzyme system within 3 weeks prior to Period 01 dosing.
13)Consumption of hypericum perforatum containing products and grapefruit or grapefruit juice from 72 hours prior admission to 3 days after trail end.
14)Subject involved other clinical trials of drugs within 3 months prior to period 01 dosing.
15)Subject with abnormal laboratory tests and diagnosed by physicians as 17)Abnormal vital signs test for any one or more:
Abnormal blood pressure:
Abnormal cardiac rate:
cardiac rate higher than 50 18)Blood alcohol test values≥10mg/dL 19)Volunteer who have donated blood components within 2 weeks prior to the first dose or donated blood (more than 200 ml within 4 weeks; more than 400 ml within 60 days) prior to the first dose; Volunteer who plan to donate blood during the study or 4 weeks after study; Volunteer who lost blood (more than 50ml within 7days or more than 400ml within 30 days) for surgery.
20)Subjects not willing to follow approved methods for the duration of the study 21)ubjects having positive Serum β-hCG test. 22)Subjects plan to donate sperm during study period or 30 days after study 23)Hamilton depression Rating Scale ( 17 ) score above 7 points. 24)History of blood phobia. Subjects whom the investigator deems necessary to exclude.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Clinically significant
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraception
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Drug: abilify
Drug: Bosiqing · Drug: abilify
Drug: Bosiqing · Drug: abilify
Drug: Bosiqing · Drug: abilify
Drug: Bosiqing · Drug: abilify
Aripiprazole Orally disintegrating tablets 10mg
Aripiprazol orodispersible tablets 10mg
Pharmacokinetic parameter: Cmax
Bioequivalence based on Peak Plasma Concentration (Cmax) under fasting and fed condition
Time frame: day 54
Pharmacokinetic parameter: AUC
Bioequivalence based on Area under the plasma concentration versus time curves (AUC) under fasting and fed condition
Time frame: day 54
Adverse Events
To observe the type, incidence and severity of adverse events in the study.
Time frame: up to day 54
Started Jun 2017 (actual). Primary completion is estimated for Apr 2018, 10 months after the start.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Jul 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Aripiprazole
Chengdu Kanghong Pharmaceutical Group Co., Ltd. →